ARCHIVES

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Upton Finds Work For Former Division, Program Directors

September 14, 1979

Center Studies Prevention For Endometrial Cancer

February 25, 2005

DCCP Recompetitions Approved Board Asks Others At NIH To Help Pay For Some Resources

October 24, 1980

Ronald DePinho Apologizes, Takes Responsibility For “Morale Issues” at MD Anderson

September 27, 2013

AIDS Research Loan Repayment Program

January 10, 1992

Tacoma Tests Of Two Patients Who Received Bahamas Treatment Are Positive For AIDS; Sera Contaminated

July 12, 1985